Acoustic Microneedle Patches for Controlled Therapeutic Diffusion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional microneedle patches struggle with passive diffusion of therapeutics, making it difficult to deliver multiple controlled dosages within short time windows, especially for emergent applications like treating anaphylaxis, and often require untrained individuals to administer therapeutics like insulin or epinephrine.
Innovation Solution
A microneedle patch system with an integrated acoustic transducer that generates adjustable acoustic signals to control the diffusion of therapeutics, allowing for customizable delivery based on frequency, duty cycle, and energy density, enabling precise control over dose, rate, and time of delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If passive diffusion is used for therapeutic delivery from microneedle patches, then the delivery mechanism is simple and requires no external control, but the diffusion rate is slow and cannot deliver multiple controlled dosages within short time windows
Solution Approach 1:
The patent applies acoustic vibration through an integrated transducer to enhance therapeutic diffusion from microneedle patches. The acoustic energy creates mechanical vibrations that accelerate drug release kinetics, enabling controlled dosing within short time windows while maintaining a relatively simple patch structure.
Solution Approach 2:
The patent utilizes acoustic parameters (frequency, power, duty cycle) as controllable variables to regulate therapeutic diffusion rates. By adjusting these acoustic parameters, the system can deliver multiple controlled dosages within emergent time frames without fundamentally changing the microneedle patch structure.
2Manufacturing precision
If conventional microneedle patches are used for therapeutic delivery, then the device structure is simple, but it is challenging to deliver multiple controlled dosages within several short time windows for emergent applications
Solution Approach 1:
The patent employs acoustic parameters (frequency, power, duty cycle) as controllable variables to precisely regulate therapeutic diffusion rates. By adjusting these parameters, the system achieves accurate dosage control for multiple deliveries within emergent time frames, with the therapeutic release model calculating optimal acoustic settings based on desired diffusion outcomes.
Solution Approach 2:
The patent incorporates a therapeutic release model that calculates acoustic field distribution, streaming fields, and diffusion parameters to determine optimal acoustic signal settings. This feedback mechanism enables precise dosage control by continuously adjusting acoustic parameters based on desired therapeutic delivery outcomes.
3Adaptability or versatility
If pre-packaged products with designated dosages are used, then the product formulation is straightforward, but the dosage is not readily adjustable for any given patient
Solution Approach 1:
The patent enables dosage customization by allowing adjustment of acoustic parameters (frequency, power, duty cycle, signal delivery time) that control therapeutic diffusion rates. The therapeutic release model calculates the relationship between acoustic parameters and diffusion outcomes, enabling precise dosage adaptation for different patients and conditions without reformulating the product.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system enhances therapeutic delivery by increasing diffusion rates up to 20 mg/mL within 6 minutes, providing a controlled and adjustable delivery method suitable for self-administration, especially for urgent conditions.
Implementation Method 1
calculate a streaming field based on the acoustic field distribution
Implementation Method 2
calculate an acoustic field distribution
Implementation Method 3
conventional microneedle patch systems rely on the passive diffusion of encapsulated therapeutics from microneedle tips into the dermis of skin and deeper tissues
Data Source
AI summary
Disclosed is a system for therapeutic delivery. The system includes a microneedle patch and an acoustic transducer configured to alter the delivery of the therapeutic from the patch. The acoustic parameters may be determined from a therapeutic release model. The system may also be contained within a housing which may be at least partially removed to deliver the therapeutic. The transducer provides control over the delivery of the therapeutic.


